Comprehensive genomic profiling (CGP) of the tumor revealed high tumor mutation burden (13 mutations/Mb) and mutations of <i>TP53, RB1</i> and <i>ERCC4</i> genes. This evidence concerns the gene ERCC4 and neoplasm.